Utrecht University
- Address
- Heidelberglaan 100, 3584 CX Utrecht, The Netherlands
Analytical, Diagnostic and Therapeutic Techniques and Equipment – Therapeutics
The Department of Internal Medicine at Utrecht University is investigating novel therapeutic approaches, including the impact of medication adjustments and the safety of emerging agents.
- Evaluation of aspirin omission on bleeding and ischemic outcomes
- Safety profiling of the metabolic modulator mitapivat
- Optimization of non‑device based treatment strategies
Six investigators are conducting two active trials, aiming to refine treatment protocols while maintaining patient safety.
Cardiovascular Diseases
Research focuses on improving care for patients with acute coronary events, specifically non‑ST‑segment elevation acute coronary syndrome.
- Bleeding risk management in acute coronary syndrome
- Ischemic event prevention without compromising safety
- Clinical outcomes of revised antiplatelet regimens
The trials aim to demonstrate that modified therapy can be non‑inferior to current standards while reducing complications.
Hemic and Lymphatic Diseases
The site is evaluating therapeutic options for erythrocyte membranopathies, targeting improved patient outcomes.
- Assessment of mitapivat safety in red‑cell membrane disorders
- Investigation of metabolic support for hemolytic anemia
- Monitoring of adverse events and quality of life
By studying these rare conditions, investigators hope to expand treatment options for affected individuals.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Eurobloodnet Association1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Utrecht University
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Aspirin Omission on Bleeding and Ischemic Outcomes in Non-ST-Segment Elevation Acute Coronary Syndrome Patients | Amsterdam UMC Stichting | Phase III | Not Recruiting | May 2022 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylsalicylic Acid | 1 | Unknown | 2022-05-13 | 2022-05-13 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.